Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 11590123 Ophthalmic compositions

OverviewStructured DataIssuesContributorsActivity

All edits

Edits on 27 Apr, 2023
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 27 Apr, 2023
Infobox
Patent Citations
‌
US Patent 11020385 Combination therapy
0
Edits on 26 Apr, 2023
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 26 Apr, 2023
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 26 Apr, 2023
Edits on 4 Apr, 2023
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 4 Apr, 2023
Edits on 2 Apr, 2023
"Entity importer update"
Golden AI profile picture
Golden AI
edited on 2 Apr, 2023
Infobox
Is a
Patent
Patent
0
Patent Applicant
Aerie Pharmaceuticals
Aerie Pharmaceuticals
0
Current Assignee
Aerie Pharmaceuticals
Aerie Pharmaceuticals
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
115901230
Date of Patent
February 28, 2023
0
Patent Application Number
178588890
Date Filed
July 6, 2022
0
Patent Citations
‌
US Patent 11185538 Compositions for treating glaucoma or reducing intraocular pressure
0
‌
US Patent 11197853 Combination therapy
0
‌
US Patent 10112920 Beta- and gamma-amino-isoquinoline amide compounds and substituted benzamide compounds
0
‌
US Patent 10174017 Dual mechanism inhibitors for the treatment of disease
0
‌
US Patent 10316029 Dual mechanism inhibitors for the treatment of disease
0
‌
US Patent 10472327 6-aminoisoquinoline compounds
0
‌
US Patent 10532993 Beta- and gamma-amino-isoquinoline amide compounds and substituted benzamide compounds
0
‌
US Patent 10568878 Combination therapy
0
‌
US Patent 10588901 Combination therapy
0
‌
US Patent 10654844 Dual mechanism inhibitors for the treatment of disease
0
‌
US Patent 10858339 Aryl cyclopropyl-amino-isoquinolinyl amide compounds
0
‌
US Patent 10882840 Beta- and gamma-amino-isoquinoline amide compounds and substituted benzamide compounds
0
‌
US Patent 10899714 6-aminoisoquinoline compounds
0
‌
US Patent 11020385 Combination therapy
0
‌
US Patent 11021456 Beta- and gamma-amino-isoquinoline amide compounds and substituted benzamide compounds
0
‌
US Patent 11028081 Dual mechanism inhibitors for the treatment of disease
0
‌
US Patent 11312700 Aryl cyclopropyl-amino-isoquinolinyl amide compounds
0
‌
US Patent 11389441 Ophthalmic compositions
0
Patent Primary Examiner
‌
Yevgeny Valenrod
0
CPC Code
‌
A61K 47/26
0
‌
A61K 47/186
0
‌
A61K 47/02
0
‌
A61K 45/06
0
‌
A61K 9/08
0
‌
A61K 9/0048
0
‌
A61K 31/5575
0
‌
A61K 31/472
0
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 2 Apr, 2023
Edits on 29 Mar, 2023
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 29 Mar, 2023
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 29 Mar, 2023
Edits on 26 Mar, 2023
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 26 Mar, 2023
Edits on 24 Mar, 2023
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 24 Mar, 2023
Edits on 23 Mar, 2023
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 23 Mar, 2023
Edits on 1 Mar, 2023
"Created via: Entity Importer"
Golden AI profile picture
Golden AI
created this topic on 1 Mar, 2023
Edits made to:
Infobox (+35 properties)
Article (+337 characters)
‌

 US Patent 11590123 Ophthalmic compositions

Article

The present disclosure provides an ophthalmic composition comprising 4-(3-amino-1-(isoquinolin-6-ylamino)-1-oxopropan-2-yl)benzyl 2,4-dimethylbenzoate or its pharmaceutically acceptable salts; about 0.01% weight/volume to about 1.0% weight/volume of a buffer; and about 0.01% weight/volume to about 10% weight/volume of a tonicity agent.

Infobox
Is a
Patent
Patent
0
Patent Applicant
Aerie Pharmaceuticals
Aerie Pharmaceuticals
0
Current Assignee
Aerie Pharmaceuticals
Aerie Pharmaceuticals
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
115901230
Date of Patent
February 28, 2023
0
Patent Application Number
178588890
Date Filed
July 6, 2022
0
Patent Citations
‌
US Patent 11185538 Compositions for treating glaucoma or reducing intraocular pressure
0
‌
US Patent 11197853 Combination therapy
0
‌
US Patent 10112920 Beta- and gamma-amino-isoquinoline amide compounds and substituted benzamide compounds
0
‌
US Patent 10174017 Dual mechanism inhibitors for the treatment of disease
0
‌
US Patent 10316029 Dual mechanism inhibitors for the treatment of disease
0
‌
US Patent 10472327 6-aminoisoquinoline compounds
0
‌
US Patent 10532993 Beta- and gamma-amino-isoquinoline amide compounds and substituted benzamide compounds
0
‌
US Patent 10568878 Combination therapy
0
‌
US Patent 10588901 Combination therapy
0
‌
US Patent 10654844 Dual mechanism inhibitors for the treatment of disease
0
‌
US Patent 10858339 Aryl cyclopropyl-amino-isoquinolinyl amide compounds
0
‌
US Patent 10882840 Beta- and gamma-amino-isoquinoline amide compounds and substituted benzamide compounds
0
‌
US Patent 10899714 6-aminoisoquinoline compounds
0
‌
US Patent 11020385 Combination therapy
0
‌
US Patent 11021456 Beta- and gamma-amino-isoquinoline amide compounds and substituted benzamide compounds
0
‌
US Patent 11028081 Dual mechanism inhibitors for the treatment of disease
0
‌
US Patent 11312700 Aryl cyclopropyl-amino-isoquinolinyl amide compounds
0
‌
US Patent 11389441 Ophthalmic compositions
0
Patent Primary Examiner
‌
Yevgeny Valenrod
0
CPC Code
‌
A61K 47/26
0
‌
A61K 47/186
0
‌
A61K 47/02
0
‌
A61K 45/06
0
‌
A61K 9/08
0
‌
A61K 9/0048
0
‌
A61K 31/5575
0
‌
A61K 31/472
0

Find more entities like US Patent 11590123 Ophthalmic compositions

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo